Basilea Pharmaceutica AG Share Price
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.00 CHF | +0.39% |
|
+2.35% | -4.57% |
| 05/08 | Swiss Market Index Extends Rally; Sandoz Shares Gain | MT |
| 05/08 | Basilea Pharmaceutica Bags Additional $5 Million Funding for Antibiotic Development | MT |
| Market Cap | 64Cr 79Cr 69Cr 59Cr 110.79Cr 7.57TCr 112.55Cr 753.35Cr 295.69Cr 3.79TCr 298.5Cr 291.97Cr 13TCr | P/E 2026 * |
13.7x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 49Cr 61Cr 53Cr 45Cr 85Cr 5.8TCr 86Cr 577.29Cr 226.58Cr 2.91TCr 228.74Cr 223.73Cr 9.61TCr | EV / Sales 2026 * |
1.87x | EV / Sales 2027 * | 1.6x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| 1 day | +0.39% | ||
| 1 week | +2.35% | ||
| Current month | +0.58% | ||
| 1 month | -4.57% | ||
| 3 months | -5.26% | ||
| 6 months | -10.77% | ||
| Current year | -4.57% |
| 1 week | 50.4 |  | 52.4 |
| 1 month | 50.4 | | 54.8 |
| Current year | 47.8 | | 59.2 |
| 1 year | 44.7 | | 59.2 |
| 3 years | 32 | | 59.7 |
| 5 years | 29.55 | | 59.7 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/05/26 | Sell | -400 | 0.0030% | |||
| 25/02/26 | Fiscal year | 1,500 | 0.0113% | |||
| 20/02/26 | Sell | 600 | 0.0045% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.39% | +2.35% | +0.97% | +22.39% | 79Cr | |
| +0.65% | +2.93% | +6.54% | +15.76% | 4.95TCr | |
| +0.88% | +13.98% | +499.31% | +597.62% | 4.4TCr | |
| +2.33% | +12.80% | +22.15% | +78.82% | 3.96TCr | |
| +0.25% | +2.76% | +33.15% | +8.12% | 3.93TCr | |
| +2.21% | +6.75% | +20.20% | +47.53% | 3.24TCr | |
| -0.58% | +5.14% | - | - | 1.68TCr | |
| +0.97% | +3.92% | +32.45% | +122.58% | 1.65TCr | |
| +0.03% | +3.07% | +5.37% | +18.42% | 1.4TCr | |
| -0.79% | +15.92% | +79.70% | +22.98% | 1.28TCr | |
| Average | +0.62% | +5.67% | +77.76% | +103.80% | 2.66TCr | |
| Weighted average by Cap. | +0.89% | +6.08% | +107.47% | +139.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26Cr 33Cr 28Cr 24Cr 45Cr 3.1TCr 46Cr 308.46Cr 121.07Cr 1.55TCr 122.22Cr 119.55Cr 5.13TCr | 27Cr 33Cr 29Cr 25Cr 46Cr 3.15TCr 47Cr 313.81Cr 123.17Cr 1.58TCr 124.34Cr 121.62Cr 5.22TCr |
| Net income | 5.16Cr 6.38Cr 5.52Cr 4.73Cr 8.9Cr 607.57Cr 9.04Cr 61Cr 24Cr 304.53Cr 24Cr 23Cr 1.01TCr | 3.92Cr 4.86Cr 4.2Cr 3.6Cr 6.77Cr 462.32Cr 6.88Cr 46Cr 18Cr 231.73Cr 18Cr 18Cr 766.08Cr |
| Net Debt | -15Cr -19Cr -16Cr -14Cr -26Cr -1.77TCr -26Cr -176.06Cr -69Cr -886.2Cr -70Cr -68Cr -2.93TCr | -21Cr -27Cr -23Cr -20Cr -37Cr -2.53TCr -38Cr -252.08Cr -99Cr -1.27TCr -100Cr -98Cr -4.19TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | CHF 52.00 | +0.39% | 5,240 |
| 07/26/07 | CHF 51.80 | +0.78% | 19,271 |
| 06/26/06 | CHF 51.40 | +1.38% | 22,714 |
| 05/26/05 | CHF 50.70 | +0.40% | 34,125 |
| 04/26/04 | CHF 50.50 | -0.98% | 24,955 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
